Galapagos | GLPG - Assets

Stock Price
29.28
Daily Change
0.12 0.41%
Monthly
7.25%
Yearly
33.94%
Q1 Forecast
27.75

Galapagos reported EUR3.51B in Assets for its fiscal quarter ending in September of 2025.





Assets Change Date
argenx SE USD 7.18B 973.07M Jun/2025
AstraZeneca USD 114.46B 2.03B Sep/2025
Biogen USD 29.21B 877.3M Sep/2025
Genmab DKK 6.46B 122M Jun/2025
Gilead Sciences USD 58.53B 2.81B Sep/2025
GlaxoSmithKline GBP 61.34B 2.08B Sep/2025
GRIFOLS EUR 19.85B 86.61M Sep/2025
Hikma Pharmaceutical USD 5.55B 421M Jun/2025
Incyte USD 6.33B 509M Sep/2025
Merck EUR 50.93B 3.58B Sep/2025
Neurocrine Biosciences USD 4.27B 375.9M Sep/2025
Novartis USD 107.29B 2.89B Sep/2025
Roche Holding CHF 100.7B 5.94B Dec/2025
Sanofi EUR 126.81B 2.99B Dec/2025
UCB EUR 17.35B 1.72B Dec/2024
Vertex Pharmaceuticals USD 24.86B 825.6M Sep/2025